# MBNL1

## Overview
MBNL1 (muscleblind-like splicing regulator 1) is a gene that encodes a protein of the same name, which is a key regulator of alternative splicing in human cells. The MBNL1 protein is characterized by its four CCCH-type zinc finger domains, which facilitate its binding to RNA and are essential for its function in RNA metabolism. As a splicing regulator, MBNL1 influences the inclusion or exclusion of exons, the selection of polyadenylation sites, and the stability and localization of mRNAs. It is predominantly active in the nucleus, where it modulates the splicing of numerous target genes critical for cellular processes such as membrane dynamics, cell adhesion, and migration. MBNL1's role is particularly significant in the context of myotonic dystrophy, where its sequestration by expanded nucleotide repeats leads to disrupted RNA splicing and disease pathology (Sznajder2016Mechanistic; Venables2013MBNL1; Konieczny2016Autoregulation).

## Structure
The MBNL1 protein is characterized by its four CCCH-type zinc finger domains, which are crucial for its RNA binding function. These domains are organized into two tandem pairs: ZnF1/ZnF2 and ZnF3/ZnF4, each with distinct RNA binding affinities (Park2017Structural; González2022Cognate). The zinc fingers are defined by specific sequence motifs, with ZnF1 and ZnF3 containing a CX7CX6CX3H motif, and ZnF2 and ZnF4 containing a CX7CX4CX3H motif (Fu2011MBNL1–RNA; González2022Cognate). 

The secondary structure of MBNL1 includes alpha helices and beta sheets, forming a single globular unit with a stable hydrophobic core (Park2017Structural). The tertiary structure is stabilized by zinc coordination, with zinc ions binding to histidine and cysteine residues, which is essential for maintaining the native fold (Park2017Structural). 

MBNL1 undergoes extensive alternative splicing, resulting in at least seven mRNA variants, which can affect its function and localization (Konieczny2014MBNL). Post-translational modifications, such as phosphorylation, influence its activity and interactions (Hale2018An). The protein's ability to bind RNA is crucial for its role in regulating alternative splicing, particularly in the context of myotonic dystrophy (Edge2013Dissecting).

## Function
MBNL1 (muscleblind-like splicing regulator 1) is a crucial protein involved in the regulation of alternative splicing in healthy human cells. It plays a significant role in RNA metabolism, influencing the splicing of alternative exons, selection of polyadenylation sites, and the stability and localization of mRNAs (Konieczny2016Autoregulation). MBNL1 is predominantly active in the nucleus, where it regulates the splicing of numerous target genes essential for cellular functions such as membrane dynamics, cell adhesion, migration, and polarity (Venables2013MBNL1). 

The protein contains four zinc-finger RNA-binding domains that are critical for its splicing activity, allowing it to bind to specific RNA motifs and influence exon inclusion or exclusion (Grammatikakis2010Identification). MBNL1's splicing regulatory activity is linked to its ability to retain repeat RNA in the nucleus, preventing the production of aberrant proteins and acting as an RNA quality control mechanism (Kino2014Nuclear). 

MBNL1 is also involved in the differentiation of pluripotent stem cells into specific cell types, establishing splicing programs necessary for fibroblast differentiation (Venables2013MBNL1). Its function is essential for normal tissue development and maintaining proper RNA processing, which is crucial for healthy cellular processes (Sznajder2016Mechanistic).

## Clinical Significance
Mutations and alterations in the expression of the MBNL1 gene are closely associated with myotonic dystrophy types 1 and 2 (DM1 and DM2), which are characterized by expanded nucleotide repeats that sequester MBNL1, leading to disrupted RNA splicing. In DM1, the sequestration of MBNL1 by expanded CUG repeats in the DMPK gene results in the misregulation of alternative splicing, contributing to muscle weakness and other symptoms (Lin2006Failure; Jiang2004Myotonic). This sequestration also affects the splicing of NMDA receptor 1 mRNA, potentially contributing to memory impairment in DM1 (Jiang2004Myotonic).

In DM2, similar splicing defects occur due to the sequestration of MBNL1 by CCUG expansion mutations, particularly affecting peripheral blood and leading to mis-splicing of critical transcription factors (Sznajder2020Loss). The loss of MBNL1 function also results in widespread misregulation of alternative polyadenylation, reverting to fetal patterns in adult tissues, which is a hallmark of RNA-mediated diseases like DM (Batra2014Loss).

Additionally, specific coding variants in MBNL1 have been identified in patients with a myotonic dystrophy-like phenotype, suggesting that even in the absence of repeat expansions, MBNL1 mutations can contribute to neuromuscular disorders (Larsen2016Identification).

## Interactions
MBNL1 (muscleblind-like splicing regulator 1) is a protein that plays a significant role in RNA splicing regulation through its interactions with both nucleic acids and other proteins. MBNL1 primarily interacts with RNA via its four CCCH zinc finger (ZnF) motifs, which are highly conserved and arranged in tandem pairs. These motifs bind specifically to YGCY RNA sequences, with a preference for GC-rich stem-loop structures, which are crucial for its role in splicing regulation (Yuan2007Muscleblindlike; González2022Cognate).

MBNL1 also interacts with other proteins, such as PTB (polypyrimidine tract-binding protein), in a cooperative manner to regulate splicing. This interaction is RNA-dependent and involves the N-terminal regions of both proteins, which act as repressor domains (Gooding2013MBNL1). MBNL1 competes with U2AF65 for binding to RNA structures, specifically at the 3' end of intron 4 in the cTNT pre-mRNA, affecting the formation of the splicing complex (Warf2009The).

In the context of myotonic dystrophy type 1 (DM1), MBNL1 isoforms, particularly MBNL1 42-43, interact with Src family kinases (SFKs) through proline-rich motifs, enhancing SFK activity and contributing to altered phosphotyrosine signaling pathways in DM1 pathogenesis (Botta2013MBNL142).


## References


[1. (Lin2006Failure) Xiaoyan Lin, Jill W. Miller, Ami Mankodi, Rahul N. Kanadia, Yuan Yuan, Richard T. Moxley, Maurice S. Swanson, and Charles A. Thornton. Failure of mbnl1-dependent post-natal splicing transitions in myotonic dystrophy. Human Molecular Genetics, 15(13):2087–2097, May 2006. URL: http://dx.doi.org/10.1093/hmg/ddl132, doi:10.1093/hmg/ddl132. This article has 415 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddl132)

[2. (Venables2013MBNL1) Julian P. Venables, Laure Lapasset, Gilles Gadea, Philippe Fort, Roscoe Klinck, Manuel Irimia, Emmanuel Vignal, Philippe Thibault, Panagiotis Prinos, Benoit Chabot, Sherif Abou Elela, Pierre Roux, Jean-Marc Lemaitre, and Jamal Tazi. Mbnl1 and rbfox2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation. Nature Communications, September 2013. URL: http://dx.doi.org/10.1038/ncomms3480, doi:10.1038/ncomms3480. This article has 119 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms3480)

[3. (Edge2013Dissecting) Christopher Edge, Clare Gooding, and Christopher WJ Smith. Dissecting domains necessary for activation and repression of splicing by muscleblind-like protein 1. BMC Molecular Biology, December 2013. URL: http://dx.doi.org/10.1186/1471-2199-14-29, doi:10.1186/1471-2199-14-29. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2199-14-29)

[4. (Konieczny2014MBNL) Patryk Konieczny, Ewa Stepniak-Konieczna, and Krzysztof Sobczak. Mbnl proteins and their target rnas, interaction and splicing regulation. Nucleic Acids Research, 42(17):10873–10887, September 2014. URL: http://dx.doi.org/10.1093/nar/gku767, doi:10.1093/nar/gku767. This article has 157 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gku767)

[5. (González2022Cognate) Àlex L. González, Daniel Fernández-Remacha, José Ignacio Borrell, Jordi Teixidó, and Roger Estrada-Tejedor. Cognate rna-binding modes by the alternative-splicing regulator mbnl1 inferred from molecular dynamics. International Journal of Molecular Sciences, 23(24):16147, December 2022. URL: http://dx.doi.org/10.3390/ijms232416147, doi:10.3390/ijms232416147. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms232416147)

[6. (Hale2018An) Melissa A Hale, Jared I Richardson, Ryan C Day, Ona L McConnell, Juan Arboleda, Eric T Wang, and J Andrew Berglund. An engineered rna binding protein with improved splicing regulation. Nucleic Acids Research, 46(6):3152–3168, January 2018. URL: http://dx.doi.org/10.1093/nar/gkx1304, doi:10.1093/nar/gkx1304. This article has 20 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkx1304)

[7. (Gooding2013MBNL1) Clare Gooding, Christopher Edge, Mike Lorenz, Miguel B. Coelho, Mikael Winters, Clemens F. Kaminski, Dmitry Cherny, Ian C. Eperon, and Christopher W.J. Smith. Mbnl1 and ptb cooperate to repress splicing of tpm1 exon 3. Nucleic Acids Research, 41(9):4765–4782, March 2013. URL: http://dx.doi.org/10.1093/nar/gkt168, doi:10.1093/nar/gkt168. This article has 41 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkt168)

[8. (Grammatikakis2010Identification) Ioannis Grammatikakis, Young-Hwa Goo, Gloria V. Echeverria, and Thomas A. Cooper. Identification of mbnl1 and mbnl3 domains required for splicing activation and repression. Nucleic Acids Research, 39(7):2769–2780, November 2010. URL: http://dx.doi.org/10.1093/nar/gkq1155, doi:10.1093/nar/gkq1155. This article has 43 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkq1155)

[9. (Botta2013MBNL142) A Botta, A Malena, E Tibaldi, L Rocchi, E Loro, E Pena, L Cenci, E Ambrosi, M C Bellocchi, M A Pagano, G Novelli, G Rossi, H L Monaco, E Gianazza, B Pantic, V Romeo, O Marin, A M Brunati, and L Vergani. Mbnl142 and mbnl143 gene isoforms, overexpressed in dm1-patient muscle, encode for nuclear proteins interacting with src family kinases. Cell Death &amp; Disease, 4(8):e770–e770, August 2013. URL: http://dx.doi.org/10.1038/cddis.2013.291, doi:10.1038/cddis.2013.291. This article has 25 citations.](https://doi.org/10.1038/cddis.2013.291)

[10. (Sznajder2020Loss) Łukasz J. Sznajder, Marina M. Scotti, Jihae Shin, Katarzyna Taylor, Franjo Ivankovic, Curtis A. Nutter, Faaiq N. Aslam, S. H. Subramony, Laura P. W. Ranum, and Maurice S. Swanson. Loss of mbnl1 induces rna misprocessing in the thymus and peripheral blood. Nature Communications, April 2020. URL: http://dx.doi.org/10.1038/s41467-020-15962-x, doi:10.1038/s41467-020-15962-x. This article has 17 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-020-15962-x)

[11. (Yuan2007Muscleblindlike) Y. Yuan, S. A. Compton, K. Sobczak, M. G. Stenberg, C. A. Thornton, J. D. Griffith, and M. S. Swanson. Muscleblind-like 1 interacts with rna hairpins in splicing target and pathogenic rnas. Nucleic Acids Research, 35(16):5474–5486, August 2007. URL: http://dx.doi.org/10.1093/nar/gkm601, doi:10.1093/nar/gkm601. This article has 178 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkm601)

[12. (Park2017Structural) Sangho Park, Priti Deka Phukan, Markus Zeeb, Maria A. Martinez-Yamout, H. Jane Dyson, and Peter E. Wright. Structural basis for interaction of the tandem zinc finger domains of human muscleblind with cognate rna from human cardiac troponin t. Biochemistry, 56(32):4154–4168, July 2017. URL: http://dx.doi.org/10.1021/acs.biochem.7b00484, doi:10.1021/acs.biochem.7b00484. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.biochem.7b00484)

[13. (Larsen2016Identification) Mirjam Larsen, Wolfram Kress, Benedikt Schoser, Ute Hehr, Clemens R Müller, and Simone Rost. Identification of variants in mbnl1 in patients with a myotonic dystrophy-like phenotype. European Journal of Human Genetics, 24(10):1467–1472, May 2016. URL: http://dx.doi.org/10.1038/ejhg.2016.41, doi:10.1038/ejhg.2016.41. This article has 5 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2016.41)

[14. (Fu2011MBNL1–RNA) Yuan Fu, Sreenivasa Rao Ramisetty, Nejmun Hussain, and Anne M. Baranger. Mbnl1–rna recognition: contributions of mbnl1 sequence and rna conformation. ChemBioChem, 13(1):112–119, November 2011. URL: http://dx.doi.org/10.1002/cbic.201100487, doi:10.1002/cbic.201100487. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cbic.201100487)

[15. (Warf2009The) M. Bryan Warf, Julien V. Diegel, Peter H. von Hippel, and J. Andrew Berglund. The protein factors mbnl1 and u2af65 bind alternative rna structures to regulate splicing. Proceedings of the National Academy of Sciences, 106(23):9203–9208, June 2009. URL: http://dx.doi.org/10.1073/pnas.0900342106, doi:10.1073/pnas.0900342106. This article has 119 citations.](https://doi.org/10.1073/pnas.0900342106)

[16. (Jiang2004Myotonic) Hong Jiang, Ami Mankodi, Maurice S. Swanson, Richard T. Moxley, and Charles A. Thornton. Myotonic dystrophy type 1 is associated with nuclear foci of mutant rna, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Human Molecular Genetics, 13(24):3079–3088, October 2004. URL: http://dx.doi.org/10.1093/hmg/ddh327, doi:10.1093/hmg/ddh327. This article has 437 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddh327)

[17. (Sznajder2016Mechanistic) Łukasz J. Sznajder, Michał Michalak, Katarzyna Taylor, Piotr Cywoniuk, Michał Kabza, Agnieszka Wojtkowiak-Szlachcic, Magdalena Matłoka, Patryk Konieczny, and Krzysztof Sobczak. Mechanistic determinants of mbnl activity. Nucleic Acids Research, pages gkw915, October 2016. URL: http://dx.doi.org/10.1093/nar/gkw915, doi:10.1093/nar/gkw915. This article has 23 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkw915)

[18. (Konieczny2016Autoregulation) Patryk Konieczny, Ewa Stepniak-Konieczna, Katarzyna Taylor, Łukasz J. Sznajder, and Krzysztof Sobczak. Autoregulation of mbnl1 function by exon 1 exclusion from mbnl1 transcript. Nucleic Acids Research, 45(4):1760–1775, November 2016. URL: http://dx.doi.org/10.1093/nar/gkw1158, doi:10.1093/nar/gkw1158. This article has 39 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkw1158)

[19. (Kino2014Nuclear) Yoshihiro Kino, Chika Washizu, Masaru Kurosawa, Yoko Oma, Nobutaka Hattori, Shoichi Ishiura, and Nobuyuki Nukina. Nuclear localization of mbnl1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins. Human Molecular Genetics, 24(3):740–756, September 2014. URL: http://dx.doi.org/10.1093/hmg/ddu492, doi:10.1093/hmg/ddu492. This article has 55 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddu492)

[20. (Batra2014Loss) Ranjan Batra, Konstantinos Charizanis, Mini Manchanda, Apoorva Mohan, Moyi Li, Dustin J. Finn, Marianne Goodwin, Chaolin Zhang, Krzysztof Sobczak, Charles A. Thornton, and Maurice S. Swanson. Loss of mbnl leads to disruption of developmentally regulated alternative polyadenylation in rna-mediated disease. Molecular Cell, 56(2):311–322, October 2014. URL: http://dx.doi.org/10.1016/j.molcel.2014.08.027, doi:10.1016/j.molcel.2014.08.027. This article has 244 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.molcel.2014.08.027)